CIK 0001759138 · Non-accelerated filer<br>Smaller reporting company
Cabaletta Bio, Inc.
Sign in to watch- Ticker
- CABA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 759-3100
- Business address
- 2929 ARCH STREET, SUITE 600, PHILADELPHIA, PA, 19104
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-01 | Stalter John Brian General Counsel | Grant or award · Stock Option (Right to Buy) | +64,500 | 64,500 | ||
| 2021-03-01 | Marda Anup Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2021-03-01 | Nichtberger Steven President & CEO | Grant or award · Stock Option (Right to Buy) | +333,500 | 333,500 | ||
| 2021-03-01 | Chang David J. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +113,500 | 113,500 | ||
| 2021-03-01 | Binder Gwendolyn EVP, Science & Technology | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2021-01-12 | 5AM Ventures V, L.P. 10% owner | Sale | −74,470 | $13.00 | $968K | 2,614,575 |
| 2021-01-12 | 5AM Ventures V, L.P. 10% owner | Sale | −10,530 | $13.00 | $137K | 369,688 |
| 2021-01-08 | 5AM Ventures V, L.P. 10% owner | Sale | −264,589 | $13.00 | $3.4M | 2,689,045 |
| 2021-01-08 | 5AM Ventures V, L.P. 10% owner | Sale | −37,411 | $13.00 | $486K | 380,218 |
| 2020-12-10 | 5AM Ventures V, L.P. 10% owner | Sale | −261,084 | $14.75 | $3.9M | 2,953,634 |
| 2020-12-10 | 5AM Ventures V, L.P. 10% owner | Sale | −36,916 | $14.75 | $545K | 417,629 |
| 2020-12-08 | Nichtberger Steven President & CEO | Grant or award · Stock Option (Right to Buy) | +93,226 | 93,226 | ||
| 2020-09-14 | Stalter John Brian General Counsel | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2020-03-01 | Nichtberger Steven President & CEO | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2020-03-01 | Chang David J. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +38,238 | 38,238 | ||
| 2020-03-01 | Marda Anup Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +24,711 | 24,711 | ||
| 2020-02-11 | DANIELS BRIAN Director | Grant or award · Stock Option (Right to Buy) | +44,000 | 44,000 | ||
| 2019-10-29 | 5AM Ventures V, L.P. 10% owner | Conversion | +3,214,721 | 3,214,721 | ||
| 2019-10-29 | 5AM Ventures V, L.P. 10% owner | Purchase | +454,545 | $11.00 | $5.0M | 454,545 |
| 2019-10-29 | 5AM Ventures V, L.P. 10% owner | Conversion · Series A Preferred Stock | −3,146,551 | 0 |
Page 12 of 13 · 256 trades